Get All Access for FREEMarket News & Research,
Live Transcripts & Audio,
and a whole lot more…
In 2018, $GM will continue its product momentum with the introduction of its all-new full-size trucks, the Chevrolet Silverado and GMC Sierra. This year, $GM will gain the benefit of a full year of volume from the ongoing launches of its newest crossovers, the Chevrolet Traverse, Buick Enclave and GMC Terrain.
$GM's wholesales for 4Q17 decreased 162,000 units year-over-year. This declined was driven primarily by decreased North American volume due to the actions taken in mid-size and compact passenger cars to match supply with demand and right size dealer inventory.
$GM's net revenue for 4Q17 decreased by $2.2Bil year-over-year. The decline was primarily due to planned downtime and other actions in North America to match supply with demand, partially offset by growth at GM Financial and increased price and mix.
$GM slipped to a loss in 4Q17 from a profit last year, due to a $7.3Bil impact of tax expense from tax reform and $2.3Bil valuation allowance from sale of Opel/Vauxhall Business. Net loss was $5.17Bil or $3.65 per share compared to a profit of $1.84Bil or $1.19 per share a year ago. Revenue fell 5.5% to $37.7Bil. Non-GAAP EPS grew 21.3% to $1.65.
Medical research firm $TMO reported a decline in 4Q17 profit, owing to higher income tax provision. Earnings dropped to $528MM or $1.30 per share from $630MM or $1.59 per share in 4Q16. On an adjusted basis, earnings rose 16% to $2.79 per share. Revenues, meanwhile moved up 22% to $6.05BIl, helped by gains from acquisitions and favorable currency.
$DHR said it expects 1Q18 earnings per share to be in the range of $0.71 to $0.74. Adjusted earnings are estimated to be between $0.90 per share and $0.93 per share. For fiscal 2018, the company anticipates that GAAP earnings per share will be in the $3.50-$3.60 range, and non-GAAP earnings between $4.25 per share and $4.35 per share.
Technology firm $DHR reported strong growth in 4Q17 earnings as an upturn in sales more than offset higher taxes. Sales moved up 11% to $5Bil, resulting in a 13% increase in earnings to $1.21 per share. Non-GAAP earnings advanced 13% to $1.19 per share. Strong performance by the recently acquired businesses also contributed to the topline growth.
$ISRG reported a loss for 4Q17, impacted by the Tax Cuts and Jobs Act. Net loss for the quarter was $38.8MM or $0.35 per share compared to a net income of $204MM or $1.71 per share a year ago. Revenue surged 17.9% to $892.4MM, driven by increased procedures and systems placements. On an adjusted basis $ISRG earned $2.54 per share, up 25.1% YoY.
Waters' fourth quarter sales rose 9% to $687.3MM backed by strong performance from its pharma and government/academic markets. $WAT reported a loss of $4.44 per share, which includes a $550MM charge related to tax reforms. On a non-GAAP basis, EPS increased 14% to $2.51. Recurring revenues grew 12%, while instruments reported 7% sales growth.